According to Fox News, new research reveals that cold sores, caused by the herpes simplex virus, may play a significant role in the development of Alzheimer's disease (source: Fox News, May 23, 2025). This development has triggered notable trading activity in biotech stocks specializing in antiviral treatments, such as those focusing on HSV-1 therapies. Additionally, crypto tokens linked to healthcare innovation, such as Healthereum and Genecoin, have seen increased volume as traders anticipate heightened investor interest in blockchain-based medical research solutions. The news highlights the growing intersection of medical breakthroughs and digital asset markets, suggesting traders should monitor both biotech equities and health-focused crypto assets for volatility.